Niagen Bioscience, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Niagen Bioscience, Inc. now
Current reporting with the operating signal separated from the noise.
Niagen Bioscience, Inc. (NAGE) Q2 2026 Earnings Call Transcript
Investors are testing whether Niagen Bioscience, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
The story matters when it changes Niagen Bioscience, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Niagen Bioscience, Inc. (NAGE) Discusses Strategic Expansion Into Pharmaceutical Development and NB4168 Drug Program Transcript
The story matters when it changes Niagen Bioscience, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
The story matters when it changes Niagen Bioscience, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Niagen Bioscience, Inc. Rings the Nasdaq Stock Market Closing Bell
Investors are testing whether Niagen Bioscience, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025
The story matters when it changes Niagen Bioscience, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest NAGE filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Niagen Bioscience, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
SEARCH Q1 COVERAGE →Second quarter
Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →